Authors: Roehrborn, CG McConnell, J Bonilla, J Rosenblatt, S Hudson, PB Malek, GH Schellhammer, PF Bruskewitz, R Matsumoto, AM Harrison, LH Fuselier, HA Walsh, P Roy, J Andriole, G Resnick, M Waldstreicher, J

Citation: Cg. Roehrborn et al., Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia, J UROL, 163(1), 2000, pp. 13-20

Authors: Klimberg, IW Malek, GH Cox, CE Patterson, AL Whalen, E Kowalsky, SF Echols, RM

Citation: Iw. Klimberg et al., Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery, J ANTIMICRO, 43, 1999, pp. 77-84

Authors: Hudson, PB Boake, R Trachtenberg, J Romas, NA Rosenblatt, S Narayan, P Geller, J Lieber, MM Elhilali, M Norman, R Patterson, L Perreault, JP Malek, GH Bruskewitz, RC Roy, JB Ko, A Jacobsen, CA Stoner, E

Citation: Pb. Hudson et al., Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years, UROLOGY, 53(4), 1999, pp. 690-695

Authors: Roehrborn, CG McConnell, JD Lieber, M Kaplan, S Geller, J Malek, GH Castellanos, R Coffield, S Saltzman, B Resnick, M Cook, TJ Waldstreicher, J

Citation: Cg. Roehrborn et al., Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia, UROLOGY, 53(3), 1999, pp. 473-480